A
Ashok Kumar
Researcher at Athens Regional Medical Center
Publications - 3
Citations - 899
Ashok Kumar is an academic researcher from Athens Regional Medical Center. The author has contributed to research in topics: Prospective cohort study & Psoriatic arthritis. The author has an hindex of 3, co-authored 3 publications receiving 707 citations.
Papers
More filters
Journal ArticleDOI
The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria
Fereydoun Davatchi,Samir H. Assaad-Khalil,Kenneth T. Calamia,J. E. Crook,Bahar Sadeghi-Abdollahi,Michael Schirmer,T. Tzellos,Christos C. Zouboulis,M. Akhlagi,A. Al-Dalaan,Z. S. Alekberova,A. A. Ali,A. Altenburg,E. Arromdee,M. Baltaci,M. Bastos,S. Benamour,I. Ben Ghorbel,Ayşe Boyvat,L. Carvalho,WenChieh Chen,E. Ben-Chetrit,Cheyda Chams-Davatchi,J. A. Correia,J. Crespo,Carlos Tadeu dos Santos Dias,Y. Dong,F. Paixão-Duarte,K. Elmuntaser,A. V. Elonakov,J. Graña Gil,Ali Akbar Haghdoost,R. M. Hayani,Habib Houman,A. R. Isayeva,Ahmadreza Jamshidi,Phaedon G. Kaklamanis,Ashok Kumar,Athanassios Kyrgidis,Wafa Madanat,Abdolhadi Nadji,Kenichi Namba,Shigeaki Ohno,I. Olivieri,J. Vaz Patto,Nicolò Pipitone,M. V. De Queiroz,F. Ramos,C. Resende,C. M. Rosa,Carlo Salvarani,M. J. Serra,Farhad Shahram,Hormoz Shams,Khalifa E. Sharquie,M. Sliti-Khanfir,T. Tribolet De Abreu,C. Vasconcelos,Joana Vedes,Bertrand Wechsler,Y. K. Cheng,Zilong Zhang,N. Ziaei +62 more
TL;DR: Behçet's disease (BD) is a chronic, relapsing, inflammatory vascular disease with no pathognomonic test.
Journal ArticleDOI
Comparative analysis of Behcet's disease in the APLAR region
Fereydoun Davatchi,Farhad Shahram,Ashok Kumar,Yew Kuang Cheng,Cheung Tak Cheong,Andrea Bendrups +5 more
TL;DR: Despite the percentage difference among some countries, the general pattern of the disease was the same, suggesting that the minor differences seen in different parts of the world were not enough to call the disease a syndrome, or to differentiate Behcet's disease of the Silk Road from those seen in Western countries.
Journal ArticleDOI
Experience with anti‐tumor necrosis factor‐α therapy in India
TL;DR: Infliximab showed expected efficacy in SpA, RA and JIA and the lone study on etanercept showed good efficacy in 40 patients with RA, however, seven serious adverse events occurred.